As an important constituent of CD4+ T cells, Tregs have been reported to promote tumor progression by shaping the immunosuppressive microenvironment32, and their infiltration frequency was substantially increased in the LN-out group, which was validated in lymph node sections (Supplementary Fig. 5a–c). This evidence concerns the gene CD4 and neoplasm.